Funding for this research was provided by:
Research Trainees Coordinating Centre (CS-2016-16-011)
Article History
Received: 16 September 2021
Accepted: 17 September 2021
First Online: 7 October 2021
Declarations
:
: KCT declares no competing interests. MS‐H is on the Editorial Board for ICM, an investigator on the REMAP-CAP trial, led the WHO REACT PMA on IL-6 antagonists. YA is on the Editorial Board for ICM and is an investigator on the REMAP-CAP trial.
Free to read: This content has been made available to all.